Clinical trial
A Study of Controlled-Release Carvedilol Compared to Immediate-Release…
NCT00444834 · Egalet Ltd, Industry · Terminated
Key facts
| NCT number | NCT00444834 |
|---|---|
| Title | A Study of Controlled-Release Carvedilol Compared to Immediate-Release Carvedilol in Patients With Primary Hypertension |
| Official title | A Phase II, Multi-center, Multiple-dose, Double-blind, Randomized, Crossover Study Comparing the Pharmacodynamic Effects of a Once-daily Controlled-Release Carvedilol (CRC; Egalet® Formulation) and an Immediate-Release Carvedilol (IRC) Formulation in Patients With Primary Hypertension |
| Lead sponsor | Egalet Ltd, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Carvedilol |
| Enrollment | 14 |
| Start date | Apr 1, 2007 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Mar 8, 2007 |
| Last update posted | Aug 29, 2016 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: